China's Government Investment, Policies Sustain IVD Market With High Double-digit Growth
This article was originally published in PharmAsia News
Executive SummarySHANGHAI - China's in vitro diagnostics market was valued at $2 billion in 2009 and is expected to keep a steady pace of 18.5 percent compound annual growth rate in the next three to five years, according to global consulting company Frost & Sullivan
You may also be interested in...
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).